---
kind: "section"
citation: "42 U.S.C. § 300cc–11"
title: "42"
title_heading: "The Public Health and Welfare"
number: "300cc–11"
heading: "Clinical evaluation units at National Institutes of Health"
release: "119-102"
date: "2026-07-12"
url: "https://uscodex.org/usc/42/300cc-11"
units:
  - "Chapter 6A — Public Health Service"
  - "Subchapter XXI — Research with Respect to Acquired Immune Deficiency Syndrome"
  - "Part B — Research Authority"
---

# §300cc–11. Clinical evaluation units at National Institutes of Health

- (a) **In general—** The [Secretary](/usc/42/201.md?p=c), acting through the [Director](/usc/42/11851.md?p=5) of the National Cancer Institute and the [Director](/usc/42/11851.md?p=5) of the National Institute of Allergy and Infectious Diseases, shall for each such Institute establish a clinical evaluation unit at the Clinical Center at the National Institutes of Health. Each of the clinical evaluation units—
  - (1) shall conduct clinical evaluations of experimental [treatments](/usc/42/11851.md?p=11) for acquired immune deficiency syndrome developed within the preclinical [drug](/usc/42/11851.md?p=4) development [program](/usc/42/274l–1.md?p=4), including evaluations of methods of diagnosing immune deficiency and evaluations of methods of predicting, diagnosing, preventing, and treating opportunistic cancers and infectious diseases; and
  - (2) may conduct clinical evaluations of experimental [treatments](/usc/42/11851.md?p=11) for such syndrome that are developed by any other national research institute of the National Institutes of Health or by any other entity.
- (b) **Personnel and administrative support—**
  - (1) For the purposes described in [subsection (a)](#a), the [Secretary](/usc/42/201.md?p=c), acting through the [Director](/usc/42/11851.md?p=5) of the National Institutes of Health, shall provide each of the clinical evaluation units required in such subsection—
    - (A)
      - (i) with not less than 50 beds; or
      - (ii) with an outpatient clinical capacity equal to not less than twice the outpatient clinical capacity, with respect to acquired immune deficiency syndrome, possessed by the Clinical Center of the National Institutes of Health on June 1, 1988; and
    - (B) with such personnel, such administrative support, and such other support [services](/usc/42/201.md?p=a) as may be necessary.
  - (2) Facilities, personnel, administrative support, and other support [services](/usc/42/201.md?p=a) provided pursuant to [paragraph (1)](#b-1) shall be in addition to the number or level of facilities, personnel, administrative support, and other support [services](/usc/42/201.md?p=a) that otherwise would be available at the Clinical Center at the National Institutes of Health for the provision of clinical care for individuals with diseases or disorders.
- (c) **Authorization of appropriations—** For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary.

## Source credit

(July 1, 1944, ch. 373, title XXIII, § 2311, as added Pub. L. 100–607, title II, § 201(4), Nov. 4, 1988, 102 Stat. 3066; amended Pub. L. 103–43, title XVIII, § 1811(2), June 10, 1993,107 Stat. 199.)

## Notes

### Editorial Notes

### Prior Provisions

A prior section 300cc–11, act July 1, 1944, § 2312, was successively renumbered by subsequent acts and transferred, see section 238i of this title.

### Amendments

1993—Subsec. (a)(1). Pub. L. 103–43 inserted before semicolon at end “, including evaluations of methods of diagnosing immune deficiency and evaluations of methods of predicting, diagnosing, preventing, and treating opportunistic cancers and infectious dis­eases”.